Sign Up Today and Learn More About NVision Imaging Technologies Stock
Invest in or calculate the value of your shares in NVision Imaging Technologies or other pre-IPO companies through EquityZen's platform.
NVision Imaging Technologies Stock
NVision Imaging Technologies develops Quantum MRI agents for assessing early patient response to treatment at the metabolic level.
About NVision Imaging Technologies Stock
Founded
2015
Industries
Science and Engineering, Health Care, Biotechnology
NVision Imaging Technologies Press Mentions
Stay in the know about the latest news on NVision Imaging Technologies
Systems and methods for generation of hyperpolarized materials
patents • May 04, 2025
Systems and methods for generation of hyperpolarized materials
patents • May 04, 2025
Systems and methods for hyperpolarized nuclear magnetic resonance spectroscopy …
patents • Apr 02, 2025
Systems and methods for spin-network labeled magnetic resonance imaging
patents • Apr 02, 2025
Systems and methods for generation of hyperpolarized materials
patents • Feb 08, 2025
NVision Imaging Technologies Management
Leadership team at NVision Imaging Technologies
Founding member, CEO
Sella Brosh
Co-Founder, CTO
Ilai Schwartz
Join now and verify your accreditation status to gain access to:
- NVision Imaging Technologies Current Valuation
- NVision Imaging Technologies Stock Price
- NVision Imaging Technologies Management
- Available deals in NVision Imaging Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NVision Imaging Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- NVision Imaging Technologies Revenue and Financials
- NVision Imaging Technologies Highlights
- NVision Imaging Technologies Business Model
- NVision Imaging Technologies Risk Factors
- NVision Imaging Technologies Research Report from SACRA Research
Trading NVision Imaging Technologies Stock
How to invest in NVision Imaging Technologies stock?
Accredited investors can buy pre-IPO stock in companies like NVision Imaging Technologies through EquityZen funds. These investments are made available by existing NVision Imaging Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NVision Imaging Technologies stock?
Shareholders can sell their NVision Imaging Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."